Enable Injections is a startup that can aid hospitals, physicians, and patients by ensuring more convenient medicine injections in home with more compliance. Enable Injections bet on SAP for future proofing as it grows.
Qualcomm plans to take on Intel in laptops as well as IoT devices and other areas. AWS cooks up its own Arm processors for its cloud instances with better price and performance than current Intel-based instances.
First AWS launches Arm-based Graviton2 processors and then Qualcomm targets Intel-based laptops. Here's a recap of a rough week.
Interim CEO Marty Cole said the company executed well and added that the Cloudera Data Platform offers customers a competitive set of capabilities.
DocuSign is showing early traction for its Agreement Cloud.
The bet is that Qualcomm can combine connectivity with thin and fanless devices to win over mobile workers. The company adds that its PC plan is a marathon not a sprint.
Qualcomm's Snapdragon 865 platform aims to spur 5G smartphone upgrades with a dose of camera enhancements and AI tools that may redefine premium device experiences.
The company projected fiscal 2020 subscription revenue of $3.085 billion to $3.087 billion.
For Verizon, the win with the AWS partnership is more enterprise 5G clients. AWS gets a network partner for edge computing services.
For Qualcomm, the launch of the Snapdragon 865 Mobile Platform and Snapdragon 765/765G will be welcome news for device manufacturers.
